US Patent Issued to Amgen, VIGIL NEUROSCIENCE on Sept. 30 for "Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use" (Canadian, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,425, issued on Sept. 30, was assigned to Amgen Inc. (Thousand Oaks, Calif.) and VIGIL NEUROSCIENCE INC. (Watertown, Mass.).

"Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use" was invented by Lara C. Czabaniuk (Thousand Oaks, Calif.), Timothy Hopper (Thousand Oaks, Calif.), Jonathan B. Houze (Cambridge, Mass.), Jane Panteleev (Thousand Oaks, Calif.), Gwenaella Rescourio (Thousand Oaks, Calif.), Vincent Santora (Thousand Oaks, Calif.), Haoxuan Wang (Thousand Oaks, Calif.), Ryan D. White (Thousand Oaks, Calif.), Alice R. Wong (Thousand Oaks, Calif.), Yongwei Wu (Thousand Oaks, Calif.), Maxence Bos (Saint-Laurent, Canada), John Ma...